Personalis and Tempus AI are adding colorectal cancer as a new indication to their existing commercialization agreement.

Frontier Capital Management, an investment management company, released its “Frontier Small Cap Growth Fund” first quarter ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the expansion of its care pathway intelligence platform, ...

Tempus AI TEM continues to push the boundaries of precision medicine through a robust pipeline of research and development (R&D) initiatives. In June, the company introduced xM, a liquid biopsy assay ...

Tempus AI TEM is entering a phase of strong operating momentum, backed by significant acceleration in both revenues and gross profit. This trend became particularly clear in the company’s last two ...

A high-level overview of Tempus AI, Inc. (TEM) stock. View (TEM) real-time stock price, chart, news, analysis, analyst reviews and more.

Explore how AI-driven Smart Diagnostics are revolutionizing healthcare, as the market shifts from research to clinical practice. Discover the potential for premium diagnostics, pricing trends, and ...

In that study, GSK is drawing on Tempus' TIME Trial Programme, a just-in-time network of providers that supports patient identification, site activation, and clinical trial enrolment.

AI Stocks Soaring Today: BigBear.ai (BBAI), Tempus AI (TEM), SoundHound AI (SOUN) AI stocks are red-hot today. Last night Alphabet (Nasdaq: GOOGL) reported earnings and its stock is down 8% today.

To improve health equity among their employees and communities, businesses will need to invest in a multiyear effort and equip themselves with the right leadership, resources, and processes.